Veterinary Medicines

Benazepril hydrochloride 20 mg tablets for dogs

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Benazepril hydrochloride 20 mg tablets for dogs
Benakor Vet. 20 mg tabletter
Active substance:
  • Benazepril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    20.00
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Carton box containing 6 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 7 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 6 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 5 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 7 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 4 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 4 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 3 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 2 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
  • Carton box containing 1 PVC-PE-PVDC-Alu-foil blisters of 14 tablets
  • Carton box containing 2 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 1 Alu-Alu-foil blisters blisters of 14 tablets
  • Carton box containing 5 Alu-Alu -foil blisters blisters of 14 tablets each
  • Carton box containing 3 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 40766
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0125/003
Concerned member states:
  • Denmark
  • Germany
  • Greece
  • Hungary
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 20 MG)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."